john capodanno

US Healthcare Comms Lead @FTI_SC. Fascinated by where science can take us. Appreciate art, clever turn of phrase & Scotch. Proud father/NY'er. Opinions my own.

[CenterForBiosimilars @BiosimCenter]

A representative from Pfizer told The Center for Biosimilars that the company has terminated 5 of its preclinical biosimilar programs in order to reallocate resources to novel drug programs in disease states with few or no available treatment options. https://t.co/oHSRuTDre8

[Jill Notte @JillNotte]

Great reference for 2019 from @PharmExec

[john capodanno @John_Capodanno]

#BigPharma is adopting the best practices of the #biotech industry, which thrives on innovation and breakthrough research. This #FTIJournal explains what they need to do in 5 steps: https://t.co/pvq2DnrBF2

[john capodanno @John_Capodanno]

#Investors have long been aware of the risks in doing #business in emerging markets – @FTI_SC_Research survey here: https://t.co/nEu7dlDRUF

[john capodanno @John_Capodanno]

#Scientists creating innovative drugs are pissed that patients cannot get access to drugs. #PrixGalien

[john capodanno @John_Capodanno]

"Opinions are not science" - particularly in our fight against cancer. Promise & Politics at #PrixGalien

[john capodanno @John_Capodanno]

Readying for pricing fight, drug lobby to add $100 million to coffers via @statnews https://t.co/4bVrAs8NNK

[john capodanno @John_Capodanno]

Researchers Create A Gene Therapy Treatment That Prevents Alzheimer's Disease via @forbes https://t.co/q6QlUNeURq

[john capodanno @John_Capodanno]

Woe to pharmas that rely on price hikes, analyst says. Who can go without? BMS, Lilly and Regeneron, for three https://t.co/88hk50xlVf

[john capodanno @John_Capodanno]

Allergan not slowing down as it strikes potential $1.5B AstraZeneca/Amgen GI drug pact https://t.co/XOxQKpnpdT

[john capodanno @John_Capodanno]

The Allergan megadeal speculation--now featuring Gilead--just won't stop https://t.co/JboGpQ0coW

[john capodanno @John_Capodanno]

Gene therapy startup bags cash to fund preclinical work in Huntington's, Alzheimer's https://t.co/Im40c5RkTk

[john capodanno @John_Capodanno]

CRISPR cuts out $90M IPO bid as another gene editing biotech goes public https://t.co/2cPDmxoEdM

[john capodanno @John_Capodanno]

State legislatures taking action and getting more involved in #drugpricing. https://t.co/mXDFizABpP

[john capodanno @John_Capodanno]

Allergan CEO swears off big price hikes in manifesto on pharma's 'social contract' https://t.co/BqKd7LtPIQ

[The Galien Foundation @GalienFdn]

The Galien Foundation fosters, recognizes and rewards excellence in #scientificinnovation to improve the state of #humanhealth

[john capodanno @John_Capodanno]

UPDATED: As Novartis looks to play catch-up in I/O, it ends cell and gene therapy unit https://t.co/d0nJJWHgJO

[john capodanno @John_Capodanno]

Your next prescription could be for a VR headset https://t.co/Q2261ooM8u via @technology

[The Galien Foundation @GalienFdn]

The Prix Galien was created by Roland Mehl, the father of #medicalscience and modern #pharmacology.

[john capodanno @John_Capodanno]

Medicating children with ADHD keeps them safer https://t.co/yNVjdjhMZH via @WSJ